EMT is characterized by enhanced cancer cell migration and invasion, typically marked by a loss of epithelial markers, like E-cadherin and a gain of mesenchymal markers such as N-cadherin, vimentin, and transcription factors like ZEB1. The gene discussed is CDH1; the disease is cancer.